We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+6.47%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$11B
AUM Growth
+$6.3B
Cap. Flow
-$236M
Cap. Flow %
-2.13%
Top 10 Hldgs %
41.04%
Holding
1,273
New
73
Increased
578
Reduced
348
Closed
99

Sector Composition

Rank Sector Weight
1 Real Estate 62.34%
2 Technology 7.48%
3 Consumer Discretionary 3.58%
4 Healthcare 3.49%
5 Communication Services 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASMB icon
1101
Assembly Biosciences
ASMB
$498M
$3K ﹤0.01%
16
+4
+33% +$1.01K
BCRX icon
1102
BioCryst Pharmaceuticals
BCRX
$2.42B
$3K ﹤0.01%
986
+117
+13% +$501
FHN icon
1103
First Horizon
FHN
$12.2B
$3K ﹤0.01%
+325
New +$3.06K
GERN icon
1104
Geron
GERN
$898M
$3K ﹤0.01%
1,751
+871
+99% +$1.61K
MGTX icon
1105
MeiraGTx Holdings
MGTX
$1.08B
$3K ﹤0.01%
206
OMER icon
1106
Omeros
OMER
$845M
$3K ﹤0.01%
309
SRRK icon
1107
Scholar Rock
SRRK
$5.88B
$3K ﹤0.01%
168
VNDA icon
1108
Vanda Pharmaceuticals
VNDA
$304M
$3K ﹤0.01%
301
XBIT icon
1109
XBiotech
XBIT
$68.6M
$3K ﹤0.01%
164
-72
-31% -$1.24K
QTTB icon
1110
Q32 Bio
QTTB
$435M
$3K ﹤0.01%
14
TECX
1111
Tectonic Therapeutic
TECX
$536M
$3K ﹤0.01%
17
+2
+13% +$403
TVRD
1112
Tvardi Therapeutics
TVRD
$20.1M
$3K ﹤0.01%
7
EGRX
1113
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3K ﹤0.01%
82
CBAY
1114
DELISTED
Cymabay Therapeutics
CBAY
$3K ﹤0.01%
378
AMRS
1115
DELISTED
Amyris Inc.
AMRS
$3K ﹤0.01%
929
+284
+44% +$1.04K
SPPI
1116
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$3K ﹤0.01%
638
TCDA
1117
DELISTED
Tricida, Inc. Common Stock
TCDA
$3K ﹤0.01%
280
AERI
1118
DELISTED
Aerie Pharmaceuticals
AERI
$3K ﹤0.01%
261
RDUS
1119
DELISTED
Radius Health, Inc.
RDUS
$3K ﹤0.01%
261
FLXN
1120
DELISTED
Flexion Therapeutics, Inc.
FLXN
$3K ﹤0.01%
272
+57
+27% +$698
ACIU icon
1121
AC Immune
ACIU
$231M
$2K ﹤0.01%
425
AHRT
1122
AH Realty Trust
AHRT
$536M
$2K ﹤0.01%
263
-92,764
-100% -$914K
AKBA icon
1123
Akebia Therapeutics
AKBA
$338M
$2K ﹤0.01%
805
+65
+9% +$570
ANIP icon
1124
ANI Pharmaceuticals
ANIP
$1.86B
$2K ﹤0.01%
68
AUTL
1125
Autolus Therapeutics
AUTL
$389M
$2K ﹤0.01%
168

Similar funds

Daiwa Securities Group's Q3 2020 Portfolio in Review

As of Q3 2020, Daiwa Securities Group held 1,273 positions worth $11B, up 133% from $4.74B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Daiwa Securities Group's Q3 2020 filing shows 73 new, 578 increased, 348 reduced and 99 closed positions. Its largest new stake was Global X Cloud Computing ETF: 2,004,400 shares worth $49M. The largest sale was Digital Realty Trust, an estimated $308M.

By sector, the portfolio is most concentrated in Real Estate at 62% of assets, up from 58% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q3 2020 buy was Global X Cloud Computing ETF: 2,004,400 shares worth $49M.
  • Daiwa Securities Group added most to CyrusOne Inc Common Stock in Q3 2020, an estimated $268M increase.
  • Daiwa Securities Group's biggest Q3 2020 reduction was Digital Realty Trust, cutting an estimated $308M.
  • Daiwa Securities Group fully exited BWX Technologies in Q3 2020, selling an estimated $11.3M.
  • Daiwa Securities Group's ten largest holdings make up 41% of its $11B portfolio in Q3 2020.
  • Daiwa Securities Group opened 73 new positions and closed 99 in Q3 2020.
  • Daiwa Securities Group's portfolio value rose 133% quarter-over-quarter to $11B.

Based on Daiwa Securities Group's 13F filing for Q3 2020, filed 2 Nov 2020.